Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jan 17, 2018
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- NIH Operates Under a Continuing Resolution Through January 19, 2018
National Institutes of Health - Reminder: Updated Appendix Policy Eliminates Clinical Trial-Related Materials for NIH/AHRQ/NIOSH Applications Submitted to Due Dates on or After January 25, 2018
National Institutes of Health - Notice of Expiration of PAR-16-269 "NIAID Clinical Trial Implementation Grant (R01)"
National Institute of Allergy and Infectious Diseases - Notice of Clarification to RFA-AI-17-042, Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases - Notice of Expiration of PAR-16-447 " NIAMS Clinical Trial Implementation Cooperative Agreement (U01)
National Institute of Arthritis and Musculoskeletal and Skin Diseases - Notice of Intent to Publish a Funding Opportunity Announcement for Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01, Clinical Trial Optional)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism - Notice of Plans to Allow 13 NIDA Program Announcements to Expire Without Renewal and Guidance to Applicants on how to Apply for Research Grants in Those Topic Areas
National Institute on Drug Abuse - Notice of NIDCD Withdrawal from Participation in PAR-18-215 "Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01 Clinical Trial Optional)"
National Institute on Deafness and Other Communication Disorders - Notice of NIDCD Withdrawal from Participation in PAR-18-214 "Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21 Clinical Trial Optional)"
National Institute on Deafness and Other Communication Disorders - Notice of Correction to the Number of Applications per Institution Allowed for RFA DE-18-012, "NIDCR Dental Specialty and PhD Program (DSPP) (K12) Clinical Trial Not Allowed)".
National Institute of Dental and Craniofacial Research - NIDCR Announces a Pre-Application Webinar and the Availability of Answers to Questions for RFA DE-18-012 "NIDCR Dental Specialty and PhD Program (DSPP) (K12 Clinical Trial Not Allowed)"
National Institute of Dental and Craniofacial Research - Notice of NIDCR's Participation in PAR-18-009 "Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional)"
National Institute of Dental and Craniofacial Research - Notice of NIDCR's Participation in PAR-18-530 " Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)"
National Institute of Dental and Craniofacial Research - Notice of Clarification of Studies Appropriate for PAR-18-112: Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Nursing Research
Office of Dietary Supplements - Notice of Clarification of Studies Appropriate for PA-18-010: Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
National Center for Complementary and Integrative Health
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
Office of Dietary Supplements - Clarification on the Number of Applications Allowed Per Organization for RFA-DK-17-017: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases - Clarification on the Number of Applications Allowed Per Organization for RFA-DK-17-018: Ancillary Studies to the NIDDK Inflammatory Bowel Disease Genetics Consortium (R21 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases - NIBIB Notice of Clarification of Preliminary Data and Clinical Trials Support for PAR-18-207, NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
National Institute of Biomedical Imaging and Bioengineering - Notice of Key Date Changes for RFA-EY-17-003 "NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trials Not Allowed)"
National Eye Institute - Notice of Clarification of Applications Relevant to PAR-17-046 "Exploratory Research for Technology Development (R21)"
National Institute of General Medical Sciences - NHLBI Announces Plan to Fund a Framingham Heart Study Exam
National Heart, Lung, and Blood Institute - Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (UG3/UH3 - Clinical Trial Required)
National Heart, Lung, and Blood Institute
Food and Drug Administration
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (U01 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
Food and Drug Administration
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (UT1/UT2 - Clinical Trial Required)
National Heart, Lung, and Blood Institute
Food and Drug Administration
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (UT1/UT2 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
Food and Drug Administration
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (U43/U44 - Clinical Trial Required)
National Heart, Lung, and Blood Institute
Food and Drug Administration
National Center for Advancing Translational Sciences
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke - Notice of Intent to Publish a Funding Opportunity Announcement to Support New Applications in Regenerative Medicine Innovation Projects (RMIP) (U43/U44 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
Food and Drug Administration
National Center for Advancing Translational Sciences
National Eye Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke - Correction to the Application Forms Package issued for PAR-18-410 Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
National Heart, Lung, and Blood Institute - Correction to the Application Forms Package issued for PAR-18-18-407 Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
National Heart, Lung, and Blood Institute - Notice of Corrected Expiration Date for PA-15-354 "SBIR Technology Transfer (R43/R44)"
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Cancer Institute
National Eye Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Nursing Research - Notice of Corrected Expiration Date and Intent to Reissue PAR-15-277 "NINDS Exploratory Clinical Trials for Small Business (R44)"
National Institute of Neurological Disorders and Stroke - Notice of Corrected Expiration Date and Intent to Reissue PAR-15-278 "NINDS Exploratory Clinical Trials for Small Business (R42)"
National Institute of Neurological Disorders and Stroke - Notice of Expiration of PAR-17-145 "NINDS Postdoctoral Mentored Career Development Award (K01)"
National Institute of Neurological Disorders and Stroke - Notice of Expiration of PAR-16-340 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22)"
National Institute of Neurological Disorders and Stroke - Notice of Expiration of PAR-17-277 "NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention Infrastructure Resource Access (X01)"
National Institute of Neurological Disorders and Stroke - Notice of Expiration of PAR-15-195 "NeuroNEXT Infrastructure Resource Access (X01)"
National Institute of Neurological Disorders and Stroke
Requests for Applications
- Pediatric Device Consortia Grants Program (P50)
Food and Drug Administration
- Patient Safety Learning Laboratories: Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18)
Agency for Healthcare Research and Quality
- African Association for Health Professions Education and Research (R25)(Clinical Trials Not Allowed) Limited to one application per institution. UIowa applicants please see: https://uiowa.infoready4.com/#competitionDetail/1768150
John E. Fogarty International Center
Program Announcements
- Hearing Health Care for Adults: Improving Access and Affordability (R21 Clinical Trial Optional)
- Hearing Health Care for Adults: Improving Access and Affordability (R01 Clinical Trial Optional)
National Institute on Deafness and Other Communication Disorders
- Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R43/R44 Clinical Trial Optional)
- Complex Technologies and Therapeutics Development for Mental Health Research and Practice (R41/R42)
National Institute of Mental Health
- Competing Renewal Awards of SBIR Phase IIB Grants for Brain and Behavior Tools (R44 Clinical Trial Optional)
National Institute of Mental Health
- International Research Collaboration on Drug Abuse and Addiction Research (R01, Clinical Trial Optional)
National Institute on Drug Abuse
- Underactive Bladder and Detrusor Activity in Aging (R01 Clinical Trial Optional)
National Institute on Aging
National Institute of Diabetes and Digestive and Kidney Diseases
- Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional)
- Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional)
National Institute on Aging
- NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required)
- NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 - No Independent Clinical Trials)
- NIDCD Research Career Enhancement Award for Established Investigators (K18 -Clinical Trials Required)
- NIDCD Research Career Enhancement Award for Established Investigators (K18 - No Independent Clinical Trials)
National Institute on Deafness and Other Communication Disorders
- Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)
National Institute on Drug Abuse
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01 - Clinical Trial Optional)
- NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44 - Clinical Trials Optional)
National Institute of Neurological Disorders and Stroke
- Lab to Marketplace: Tools for Brain and Behavioral Research (R43/R44 - Clinical Trial Optional
National Institute of Mental Health
- New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trials Not Allowed)
National Heart, Lung, and Blood Institute
- Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (U44 - Clinical Trial Optional)
- Investigational New Drug (IND)-enabling Development of Medications to Treat Alcohol Use disorder and Alcohol-related disorders (UT2 -Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism
- Emotional Function in Normal Aging and/or MCI and AD/ADRD (R01 - Clinical Trial Optional)
- Emotional Function in Normal Aging and/or MCI and AD/ADRD (R21 - Clinical Trial Not Allowed)
National Institute on Aging
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu
